What is the scope of Homoeopathic Remedies in reducing the impact of Tension Type Headache on day to day emotions, activities and work place, which will be assessed by Headache Disability Index scale.

Scope of Homoeopathic medicines on disability and subjective distress in Tension-type Headache assessed by Headache Disability Index: An uncontrolled experiment study. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088715

Enrollment

Registered

2025-06-12

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G442- Tension-type headache

Interventions

Intervention1: Homoeopathic Medicine: Indicated homoeopathic medicine will be given. Dose and frequency of repetition are a part of management that will vary case by case, depending on the severity a

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having a clinical presentation of T.T.H. according to ICHD3 criteria. 2. Age group 18 and above 3. Patients of all Genders. 4. Patients Diagnosed for the first time as well as previously diagnosed cases but not receiving homoeopathic treatment. 5. The patient who takes Analgesics (painkillers) for the headache but is willing to taper it down or stop 6. Patients showing a Disability Score on the Headache disability index of more than 10 7. Patients who are willing to take homeopathic treatment during the acute episode of headache

Exclusion criteria

Exclusion criteria: 1. Pregnant Women. 2. Cases of Sinusitis diagnosed as per standard clinical criteria. 3. Patients having headaches due to raised Blood pressure.

Design outcomes

Primary

Measure	Time frame
To assess the improvement in the disability and subjective distress in the Tension type of headache after the intervention of homoeopathic treatment assessed by Headache disability index scale within 6 months of duration.Timepoint: 1.6 years	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Harshla Sarvagod

Dr. M. L. Dhawale Memorial Homoeopathic Institute

harshsarvagodr@gmail.com8108777599

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026